HR8000Referred to Committee

END 7-OH Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-03-19
Introduced
2
Cosponsors
HR
ⓘ
Type

Sponsor

Gus M. Bilirakis
Gus M. Bilirakis
Republican · FL · Representative
Votes with party: 98.7% (595 recorded votes)

Full profile: /officials/B001257

Source: Congress.gov · FEC

Cosponsors (2)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2026-03-19

Source: Congress.gov

Plain-English Summary

This bill would restrict or ban the production and sale of 7-hydroxymitragynine, a powerful opioid-like compound found in kratom, treating it similarly to other controlled substances under federal law. The measure would affect kratom vendors, supplement companies, and consumers who use kratom products, potentially making them illegal to distribute or possess. Law enforcement agencies would gain authority to enforce these restrictions, similar to how they handle other banned drugs.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Crime and Law Enforcement

Full Bill Text

Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 8000 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 8000 To amend the Controlled Substances Act to schedule synthetic 7- hydroxymitragynine as a Schedule I controlled substance. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 19, 2026 Mr. Bilirakis introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend the Controlled Substances Act to schedule synthetic 7- hydroxymitragynine as a Schedule I controlled substance. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``End Needless Distribution of 7-OH Act'' or the ``END 7-OH Act''. SEC. 2. SCHEDULING OF 7-HYDROXYMITRAGYNINE. Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended by adding at the end of subsection (b) of such schedule the following: ``(23) 7-hydroxymitragynine-- ``(A) including its synthetic equivalents; but ``(B) not including 7-hydroxymitragynine naturally contained in the plant of the genus and species name: Mitragyna speciosa Korth, also known as kratom.''. <all>
Open clean-text viewRead on Congress.gov →

Related legislation

Bills by the same sponsor or covering overlapping subjects.